{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:58:59Z","timestamp":1791910739387,"version":"4.3.4"},"reference-count":201,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.pharmthera.2008.10.003","type":"journal-article","created":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T08:08:42Z","timestamp":1225354122000},"page":"100-114","source":"Crossref","is-referenced-by-count":133,"title":["Behavioral analyses of GHB: Receptor mechanisms"],"prefix":"10.1016","volume":"121","author":[{"given":"Lawrence P.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Koek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P.","family":"France","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2008.10.003_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/jcp.0b013e31815a2542","article-title":"Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users","volume":"27","author":"Abanades","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1196\/annals.1369.065","article-title":"Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics","volume":"1074","author":"Abanades","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.alcalc.a008160","article-title":"An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects","volume":"31","author":"Addolorato","year":"1996","journal-title":"GHB Study Group. Alcohol Alcohol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib4","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1530-0277.1999.tb04049.x","article-title":"Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine","volume":"23","author":"Addolorato","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2044.1968.tb00119.x","article-title":"4-Hydroxybutyrate anaesthesia for cardiovascular surgery. A comparison with halothane","volume":"23","author":"Aldrete","year":"1968","journal-title":"Anaesthesia"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1096\/fj.06-6509com","article-title":"Cloning and functional characterization of a gamma-hydroxybutyrate receptor identified in the human brain","volume":"21","author":"Andriamampandry","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib7","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1096\/fj.02-0846fje","article-title":"Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB)","volume":"17","author":"Andriamampandry","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0376-8716(81)90103-4","article-title":"The effect of neuroleptics, tranquilizers, narcotics, antidepressants and anticonvulsive drugs on the alterations of mouse behaviour caused by acetaldehyde","volume":"8","author":"Andronova","year":"1981","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib9","series-title":"Report on Results of OPERATION MATISSE","author":"Association of Chief Police Officers","year":"2006"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00213-003-1744-z","article-title":"Influence of reinforcer type and route of administration on gamma-hydroxybutyrate discrimination in rats","volume":"174","author":"Baker","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.pbb.2008.02.016","article-title":"Differentiating the discriminative stimulus effects of gamma-hydroxybutyrate and ethanol in a three-choice drug discrimination procedure in rats","volume":"89","author":"Baker","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00213-005-0003-x","article-title":"Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats","volume":"181","author":"Baker","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF00435861","article-title":"Effects of baclofen on dopamine-dependent behaviors in mice","volume":"75","author":"Balsara","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib14","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/S0022-3565(25)09686-7","article-title":"Presynaptic gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB (GABAB) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB","volume":"273","author":"Banerjee","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1553-2712.2003.tb00062.x","article-title":"Gamma-hydroxybutyric acid tolerance and withdrawal in a rat model","volume":"10","author":"Bania","year":"2003","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1615\/CritRevNeurobiol.v16.i12.70","article-title":"Neurosteroidogenesis: relevance to neurosteroid actions in brain and modulation by psychotropic drugs","volume":"16","author":"Barbaccia","year":"2004","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuropharm.2005.01.026","article-title":"Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative\/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines","volume":"49","author":"Barbaccia","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib18","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0028-3908(02)00026-6","article-title":"GABAB receptor-mediated increase of neurosteroids by \u03b3-hydroxybutyric acid","volume":"42","author":"Barbaccia","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/02791072.2007.10399870","article-title":"Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study","volume":"39","author":"Barker","year":"2007","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050092","article-title":"Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB)","volume":"127","author":"Beardsley","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0741-8329(99)00085-3","article-title":"Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependent patients","volume":"20","author":"Begh\u00e8","year":"2000","journal-title":"Alcohol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib22","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1360-0443.2003.00554.x","article-title":"The role of an international nightlife resort in the proliferation of recreational drugs","volume":"98","author":"Bellis","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib23","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0024-3205(82)90624-5","article-title":"High affinity binding sites for gamma-hydroxybutyric acid in rat brain","volume":"30","author":"Benavides","year":"1982","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib24","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1126\/science.143.3610.1045","article-title":"Gamma hydroxybutyrate and gamma butyrolactone: concentration in rat tissues during anesthesia","volume":"143","author":"Bessman","year":"1964","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib25","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s11095-006-9066-6","article-title":"Alterations in neuronal transport but not blood-brain barrier transport are observed during gamma-hydroxybutyrate (GHB) sedative\/hypnotic tolerance","volume":"23","author":"Bhattacharya","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib26","first-page":"281","article-title":"Suppression of voluntary ethanol intake in rats and alcoholics by gamma-hydroxybutyric acid: a non-GABAergic mechanism","volume":"47","author":"Biggio","year":"1992","journal-title":"Adv Biochem Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0165-6147(93)90124-3","article-title":"Multiple GABAB receptors","volume":"14","author":"Bonanno","year":"1993","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0741-8329(99)00086-5","article-title":"Design and structure\u2013activity relationship analysis of ligands of gamma-hydroxybutyric acid receptors","volume":"20","author":"Bourguignon","year":"2000","journal-title":"Alcohol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib29","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/jm00400a001","article-title":"Analogues of gamma-hydroxybutyric acid. Synthesis and binding studies","volume":"31","author":"Bourguignon","year":"1988","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/283092a0","article-title":"(\u2212)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor","volume":"283","author":"Bowery","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0026-895X(25)12532-7","article-title":"Inhibition of gamma-aminobutyric acid release by gamma-aminobutyric acid agonist drugs. Pharmacology of the gamma-aminobutyric acid autoreceptor","volume":"19","author":"Brennan","year":"1981","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0317167100119304","article-title":"The treatment of narcolepsy\u2013cataplexy with nocturnal gamma-hydroxybutyrate","volume":"6","author":"Broughton","year":"1979","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib33","first-page":"23","article-title":"Effects of nocturnal gamma-hydroxybutyrate on sleep\/waking patterns in narcolepsy\u2013cataplexy","volume":"7","author":"Broughton","year":"1980","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib34","doi-asserted-by":"crossref","first-page":"227S","DOI":"10.1002\/j.1552-4604.1981.tb02599.x","article-title":"Discriminative stimulus properties of \u03949-tetrahydrocannabinol: mechanistic studies","volume":"21","author":"Browne","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib35","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1016\/S0024-3205(02)01553-9","article-title":"GABA(B)-receptor mediation of the inhibitory effect of gamma-hydroxybutyric acid on intestinal motility in mice","volume":"70","author":"Carai","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-2999(01)01334-6","article-title":"Role of GABAB receptors in the sedative\/hypnotic effect of \u03b3-hydroxybutyric acid","volume":"428","author":"Carai","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00213-003-1737-y","article-title":"Suppression of GABAB receptor function in vivo by disulfide reducing agent, DL-dithiothreitol (DTT)","volume":"174","author":"Carai","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2006.03.039","article-title":"Discriminative stimulus effects of GHB and GABA(B) agonists are differentially attenuated by CGP35348","volume":"538","author":"Carter","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugalcdep.2004.10.002","article-title":"Comparison of the behavioral effects of gamma-hydroxybutyric acid (GHB) and its 4-methyl-substituted analog, gamma-hydroxyvaleric acid (GHV)","volume":"78","author":"Carter","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib40","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1124\/jpet.102.047860","article-title":"The role of GABAB receptors in the discriminative stimulus effects of \u03b3-hydroxybutyrate in rats: time course and antagonism studies","volume":"305","author":"Carter","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib41","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.npp.1301146","article-title":"Relative abuse liability in humans: a comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB","volume":"31","author":"Carter","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib42","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/jpet.103.062950","article-title":"The discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and related compounds in rats discriminating baclofen or diazepam: the role of GABAB and GABAA receptors","volume":"309","author":"Carter","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/jpet.103.058909","article-title":"Effects of GHB on schedule-controlled responding in rats: role of GHB and GABAB receptors","volume":"308","author":"Carter","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib44","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1124\/jpet.104.077578","article-title":"Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all behavioral effects of GHB and GABAB receptor agonists","volume":"313","author":"Carter","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0304-3940(96)12589-1","article-title":"Kinetic characterisation and solubilisation of \u03b3-hydroxybutyrate receptors from rat brain","volume":"209","author":"Cash","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib46","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1046\/j.1471-4159.2003.02037.x","article-title":"Selective \u03b3-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative\/hypnotic effect of \u03b3-hydroxybutyric acid","volume":"87","author":"Castelli","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1527-3458.2004.tb00025.x","article-title":"A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor","volume":"10","author":"Castelli","year":"2004","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib48","first-page":"861","article-title":"Epidemiologic notes and reports multistate outbreak of poisonings associated with illicit use of gamma hydroxy butyrate","volume":"39","author":"Centers for Disease Control","year":"1990","journal-title":"MMWR"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib49","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1016\/j.bmcl.2005.05.011","article-title":"Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligands","volume":"15","author":"Chen","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib50","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0196-0644(98)70230-6","article-title":"Clinical course of gamma-hydroxybutyrate overdose","volume":"31","author":"Chin","year":"1998","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-2999(95)00493-5","article-title":"Oral self-administration of gamma-hydroxybutyric acid in the rat","volume":"285","author":"Colombo","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib52","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0031-9384(95)00086-X","article-title":"Blockade of the discriminative stimulus effects of \u03b3-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382","volume":"58","author":"Colombo","year":"1995","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0031-9384(98)00033-X","article-title":"Gamma-hydroxybutyric acid intake in ethanol-preferring sP and nonpreferring sNP rats","volume":"64","author":"Colombo","year":"1998","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(94)00687-3","article-title":"Cross-tolerance to ethanol and gamma-hydroxybutyric acid","volume":"273","author":"Colombo","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0031-9384(94)00215-Q","article-title":"Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: occurrence within narrow dose ranges","volume":"57","author":"Colombo","year":"1995","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0031-9384(98)00062-6","article-title":"Involvement of GABAA and GABAB receptors in the mediation of discriminative stimulus effects of \u03b3-hydroxybutyric acid","volume":"64","author":"Colombo","year":"1998","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00213-001-0951-8","article-title":"Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice","volume":"160","author":"Cook","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0736-4679(99)00163-8","article-title":"Severe gamma-hydroxybutyrate withdrawal: a case report and literature review","volume":"18","author":"Craig","year":"2000","journal-title":"J Emerg Med"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coph.2005.10.001","article-title":"Unraveling the brain targets of gamma-hydroxybutyric acid","volume":"6","author":"Crunelli","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib60","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.pbb.2004.01.009","article-title":"Comparison of the actions of gamma-butyrolactone and 1,4-butanediol in Swiss-Webster mice","volume":"77","author":"de Fiebre","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0376-8716(02)00017-0","article-title":"GHB use among Australians: characteristics, use patterns and associated harms","volume":"67","author":"Degenhardt","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib62","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.forsciint.2007.02.009","article-title":"Prevalence of gamma-hydroxybutyrate (GHB) in serum samples of amphetamine, methamphetamine and ecstasy impaired drivers","volume":"173","author":"Dresen","year":"2007","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib63","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0735-6757(91)90050-T","article-title":"\u03b3-Hydroxybutyrate: a health-food product producing coma and seizurelike activity","volume":"9","author":"Dyer","year":"1991","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib64","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejphar.2003.11.016","article-title":"Chronic 1,4-butanediol treatment in rats: cross tolerance to gamma-hydroxybutyrate and (\u00b1)-baclofen","volume":"484","author":"Eckermann","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jat\/23.3.141","article-title":"Prevalence of drugs used in cases of alleged sexual assault","volume":"23","author":"ElSohly","year":"1999","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(96)13016-0","article-title":"Gamma-hydroxybutyric acid decreases thalamic sensory excitatory postsynaptic potentials by an action on presynaptic GABAB receptors","volume":"216","author":"Emri","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib67","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/PL00005215","article-title":"Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by gamma-hydroxybutyric acid (GHBA) are specifically induced by activation of GABA(B) receptors","volume":"357","author":"Erhardt","year":"1998","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib68","article-title":"Retention of drug stimulus control in pigeons trained to a three-key morphine discrimination","author":"Evola","year":"2007","journal-title":"Abstract for the CPDD 69th Annual Scientific Meeting"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib69","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/0024-3205(83)90913-X","article-title":"Suppression of voluntary ethanol consumption in rats by gamma-butyrolactone","volume":"32","author":"Fadda","year":"1983","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib70","first-page":"447","article-title":"Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats","volume":"24","author":"Fadda","year":"1989","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib71","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1097\/00001756-200107200-00039","article-title":"Baclofen antagonises intravenous self-administration of \u03b3-hydroxybutyric acid in mice","volume":"12","author":"Fattore","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib72","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1471-4159.2001.00530.x","article-title":"\u03b3-Hydroxybutyrate modulation of glutamate levels in the hippocampus: an in vivo and in vitro study","volume":"78","author":"Ferraro","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib73","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1592\/phco.23.10.1205.32756","article-title":"From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy","volume":"23","author":"Fuller","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib74","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(89)90842-8","article-title":"Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome","volume":"30","author":"Gallimberti","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib75","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1530-0277.1992.tb00658.x","article-title":"\u03b3-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study","volume":"16","author":"Gallimberti","year":"1992","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1360-0443.1997.tb03640.x","article-title":"Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence","volume":"92","author":"Galloway","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib77","first-page":"519","article-title":"Effects of subchronic administration of gamma-hydroxybutyrate (GHB) and spatial working memory in rats","volume":"18","author":"Garc\u00eda","year":"2006","journal-title":"Psicothema"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib78","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2004.10.044","article-title":"Interaction between 1,4-butanediol and ethanol on operant responding and the cardiovascular system","volume":"506","author":"Gerak","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib79","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0022-3565(25)31488-6","article-title":"Tolerance to the effects of baclofen and gamma-butyrolactone on locomotor activity and dopaminergic neurons in the mouse","volume":"207","author":"Gianutsos","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib80","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.145.3632.583","article-title":"Differential estimation of gamma-butyrolactone and gamma-hydroxybutyric acid in rat blood and brain","volume":"145","author":"Giarman","year":"1964","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib81","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00503306","article-title":"Decreased 3H-l-quinuclidinyl benzilate binding and muscarine receptor subsensitivity after chronic gamma-butyrolactone treatment","volume":"318","author":"Giorgi","year":"1981","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib82","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(77)90096-6","article-title":"Slow wave sleep and a state resembling absence epilepsy induced in the rat by gamma-hydroxybutyrate","volume":"44","author":"Godschalk","year":"1977","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib83","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0269881105049041","article-title":"Gamma hydroxy butyrate abuse and dependency","volume":"19","author":"Gonzalez","year":"2005","journal-title":"J Psychopharm"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib84","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00213-005-2165-y","article-title":"Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons","volume":"180","author":"Goodwin","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib85","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00213-006-0534-9","article-title":"Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons","volume":"189","author":"Goodwin","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0006-8993(03)02865-8","article-title":"Quantitative autoradiographic analysis of the new radioligand [3H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid ([3H]NCS-382) at \u03b3-hydroxybutyric acid (GHB) binding sites in rat brain","volume":"979","author":"Gould","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050422","article-title":"Benzodiazepine self-administration in humans and laboratory animals \u2014 implications for problems of long-term use and abuse","volume":"134","author":"Griffiths","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib88","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/bja\/43.2.113","article-title":"Effects of methohexitone, diazepam and sodium 4-hydroxybutyrate on short-term memory","volume":"43","author":"Grove-White","year":"1971","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib89","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0006-2952(70)90251-0","article-title":"Relationship between pharmacological effects and blood and brain levels of gamma-butyrolactone and gamma-hydroxybutyrate","volume":"19","author":"Guidotti","year":"1970","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib90","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.addbeh.2006.01.009","article-title":"GHB use among gay and bisexual men","volume":"31","author":"Halkitis","year":"2006","journal-title":"Addict Behav"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib91","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.drugalcdep.2006.12.028","article-title":"Poly-club-drug use among gay and bisexual men: a longitudinal analysis","volume":"89","author":"Halkitis","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib92","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/art.23223","article-title":"Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia","volume":"58","author":"Harris","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib93","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0304-3940(90)90812-N","article-title":"Trans-gamma-hydroxycrotonic acid binding sites in brain: evidence for a subpopulation of gamma-hydroxybutyrate sites","volume":"110","author":"Hechler","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib94","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/00952999809001706","article-title":"GHB-induced delirium: a case report and review of the literature of gamma-hydroxybutyric acid","volume":"24","author":"Hernandez","year":"1998","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib95","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00005344-200412000-00002","article-title":"Mechanisms underlying the sympathomimetic cardiovascular responses elicited by \u03b3-hydroxybutyrate","volume":"44","author":"Hicks","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib96","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(83)90440-8","article-title":"Action of \u03b3-hydroxybutyrate and GABA on neurones of cultured rat central nervous system","volume":"37","author":"H\u00f6sli","year":"1983","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib97","first-page":"A213","article-title":"Narcolepsy\u2013cataplexy: action of two GABA-2 agonists, baclofen and sodium oxybate on clinical symptoms","volume":"31","author":"Huang","year":"2008","journal-title":"Sleep"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib98","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1749-6632.2002.tb04186.x","article-title":"Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB","volume":"965","author":"Itzhak","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib99","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/j.1460-9568.2003.03013.x","article-title":"Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABAB(1)-deficient mice","volume":"18","author":"Kaupmann","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib100","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0306-4522(02)00662-0","article-title":"Gamma-hydroxybutyrate receptor function determined by stimulation of rubidium and calcium movements from NCB-20 neurons","volume":"116","author":"Kemmel","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib101","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/00952990701312316","article-title":"High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users","volume":"33","author":"Kim","year":"2007","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib102","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.forsciint.2004.02.036","article-title":"GHB in postmortem toxicology. Discrimination between endogenous production from exposure using multiple specimens","volume":"143","author":"Kintz","year":"2004","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib103","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00003643-199711000-00006","article-title":"Total intravenous anaesthesia using propofol, gamma-hydroxybutyrate or midazolam in combination with sufentanil for patients undergoing coronary artery bypass surgery","volume":"14","author":"Kleinschmidt","year":"1997","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib104","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00003643-199809000-00009","article-title":"Total intravenous anaesthesia with gamma-hydroxybutyrate (GHB) and sufentanil in patients undergoing coronary artery bypass graft surgery: a comparison in patients with unimpaired and impaired left ventricular function","volume":"15","author":"Kleinschmidt","year":"1998","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib105","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/jpet.105.083394","article-title":"Discriminative stimulus effects of \u03b3-hydroxybutyrate (GHB) in rats discriminating GHB from baclofen and diazepam","volume":"314","author":"Koek","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib106","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00008877-200605000-00005","article-title":"Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone","volume":"17","author":"Koek","year":"2006","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib107","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/jpet.105.096909","article-title":"Discriminative stimulus effects of gamma-hydroxybutyrate: role of training dose","volume":"317","author":"Koek","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib108","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1124\/jpet.103.056093","article-title":"Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) in pigeons: involvement of diazepam-sensitive and -insensitive GABAA receptors and of GABAB receptors","volume":"308","author":"Koek","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib109","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-008-1160-5","article-title":"Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists","volume":"199","author":"Koek","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/FBP.0b013e3282f18d45","article-title":"Synergistic interactions between \u2018club drugs\u2019: gamma-hydroxybutyrate and phencyclidine enhance each other's discriminative stimulus effects","volume":"18","author":"Koek","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib111","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00213-007-0718-y","article-title":"Cataleptic effects of gamma-hydroxybutyrate (GHB), its precursor gamma-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348","volume":"192","author":"Koek","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib112","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0028-3908(64)90074-7","article-title":"Sodium 4-hydroxybutyrate","volume":"32","author":"Laborit","year":"1964","journal-title":"Int J Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib113","first-page":"1867","article-title":"Summary of an experimental and clinical study on a metabolic substrate with inhibitory central action: sodium 4-hydroxybutyrate","volume":"68","author":"Laborit","year":"1960","journal-title":"Presse Med"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib114","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(93)90268-M","article-title":"CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex","volume":"237","author":"Lanza","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pbb.2007.08.002","article-title":"Gamma-hydroxybutyrate (GHB) reduces operant behavior without impairing working memory in rats responding under fixed-consecutive-number schedules","volume":"88","author":"Laraway","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib116","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.forsciint.2006.08.007","article-title":"Further evidence of in vitro production of gamma-hydroxybutyrate (GHB) in urine samples","volume":"169","author":"LeBeau","year":"2007","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib117","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00002826-199202000-00008","article-title":"Baclofen intoxication: report of four cases and review of the literature","volume":"15","author":"Lee","year":"1992","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib118","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12028-008-9062-2","article-title":"Baclofen and gamma-hydroxybutyrate withdrawal","volume":"8","author":"LeTourneau","year":"2008","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib119","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0196-0644(98)70231-8","article-title":"A tale of novel intoxication: seven cases of gamma-hydroxybutyric acid overdose","volume":"31","author":"Li","year":"1998","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib120","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.drugalcdep.2005.07.010","article-title":"Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use","volume":"81","author":"Liechti","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib121","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0028-3908(99)00131-8","article-title":"\u03b3-Hydroxybutyrate is a weak agonist at recombinant GABAB receptors","volume":"38","author":"Lingenhoehl","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbrainres.2003.12.011","article-title":"Single cell RT-PCR demonstrates differential expression of GABAC receptor rho subunits in rat hippocampal pyramidal and granule cells","volume":"123","author":"Liu","year":"2004","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib123","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0091-3057(99)00046-5","article-title":"Contribution of GABAA and GABAB receptors to the discriminative stimulus produced by gamma-hydroxybutyric acid","volume":"64","author":"Lobina","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib124","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.bmc.2004.01.025","article-title":"3-Chloropropanoic acid (UMB66): a ligand for the gamma-hydroxybutyric acid receptor lacking a 4-hydroxyl group","volume":"12","author":"Macias","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib125","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-3565(25)23017-8","article-title":"A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties","volume":"255","author":"Maitre","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib126","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.neurobiolaging.2006.06.008","article-title":"Alzheimer's disease, oxidative stress and gammahydroxybutyrate","volume":"28","author":"Mamelak","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib127","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/sleep\/9.1.285","article-title":"Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings","volume":"9","author":"Mamelak","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib128","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0924-977X(97)00087-4","article-title":"Intravenous self-administration of gamma-hydroxybutyric acid in drug-na\u00efve mice","volume":"8","author":"Martellotta","year":"1998","journal-title":"Eur Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050312","article-title":"Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference paradigm","volume":"132","author":"Martellotta","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib130","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0006-2952(72)90301-2","article-title":"Conversion of 1,4-butanediol to -hydroxybutyric acid in rat brain and in peripheral tissue","volume":"21","author":"Maxwell","year":"1972","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/02791072.2001.10400479","article-title":"Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies","volume":"33","author":"McDaniel","year":"2001","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib132","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugalcdep.2004.01.012","article-title":"Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review","volume":"75","author":"McDonough","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib133","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(03)01486-9","article-title":"Evaluation of the reinforcing and discriminative stimulus effects of 1,4-butanediol and gamma-butyrolactone in rhesus monkeys","volume":"466","author":"McMahon","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib134","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0022-3565(24)29240-5","article-title":"Binding characteristics of the \u03b3-hydroxybutyric acid receptor antagonist [3H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene ethanoic acid in the rat brain","volume":"299","author":"Mehta","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib135","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0028-3908(87)90108-0","article-title":"Baclofen induces catatonia in rats","volume":"26","author":"Mehta","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib136","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0091-3057(01)00579-2","article-title":"Discrimination of gamma-hydroxybutyrate an ethanol administered separately and as a mixture in rats","volume":"70","author":"Metcalf","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib137","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nn944","article-title":"Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders","volume":"5","author":"Mignot","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib138","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/105504901750532111","article-title":"Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal","volume":"10","author":"Miotto","year":"2001","journal-title":"Am J Addict"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib139","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0166-4328(87)90012-X","article-title":"Effects of gamma-hydroxybutyrate on the performance of monkeys in a Go\/No-go visual discrimination task","volume":"26","author":"Nakamura","year":"1987","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib140","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0278-5846(98)00043-8","article-title":"Tiapride-induced catalepsy is potentiated by gamma-hydroxybutyric acid administration","volume":"22","author":"Navarro","year":"1998","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(00)00191-5","article-title":"GHB: a new and novel drug of abuse","volume":"63","author":"Nicholson","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib142","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0014-2999(79)90460-6","article-title":"Inhibition of nigral and neocortical cells by gamma-hydroxybutyrate: a microiontophoretic investigation","volume":"53","author":"Olpe","year":"1979","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib143","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ana.410060206","article-title":"\u03b3-Hydroxybutyric acid is not a GABA-mimetic agent in the spinal cord","volume":"6","author":"Osorio","year":"1979","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib144","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/00023210-200620120-00004","article-title":"Gamma-hydroxybutyrate\/sodium oxybate: neurobiology, and impact on sleep and wakefulness","volume":"20","author":"Pardi","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib145","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0024-3205(99)00163-0","article-title":"Gamma-hydroxybutyrate increases gastric emptying in rats","volume":"64","author":"Poggioli","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib146","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/alcalc\/34.1.15","article-title":"The role of \u03b3-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies","volume":"34","author":"Poldrugo","year":"1999","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib147","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0028-3908(84)90226-0","article-title":"1,4 Butanediol, \u03b3-hydroxybutyric acid and ethanol: relationships and interactions","volume":"23","author":"Poldrugo","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib148","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1196\/annals.1369.055","article-title":"Evaluation from the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines","volume":"1074","author":"Quang","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib149","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bjp.0705447","article-title":"Effects of GABA agonists on body temperature regulation in GABA(B(1))\u2212\/\u2212 mice","volume":"140","author":"Queva","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib150","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1124\/jpet.106.113886","article-title":"Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: effects of extracellular dopamine","volume":"320","author":"Raybon","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib151","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00023210-200721040-00007","article-title":"Sodium oxybate: a review of its use in the management of narcolepsy","volume":"21","author":"Robinson","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib152","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1192\/bjp.184.2.104","article-title":"Liquid ecstasy: a new kid on the dance floor","volume":"184","author":"Rodgers","year":"2004","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib153","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0006-2952(65)90073-0","article-title":"Preliminary report on the metabolism of \u03b3-butyrolactone and \u03b3-hydroxybutyric acid","volume":"14","author":"Roth","year":"1965","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib154","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0006-2952(68)90010-5","article-title":"Evidence that central nervous system depression by 1,4-butanediol in mediated through a metabolite, gamma-hydroxybutyrate","volume":"17","author":"Roth","year":"1968","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib155","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0006-2952(67)90110-4","article-title":"Dependence of rat serum lactonase upon calcium","volume":"16","author":"Roth","year":"1967","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib156","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/00952999709016901","article-title":"GHB: a home brew","volume":"23","author":"Sanguineti","year":"1997","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib157","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11916-007-0216-2","article-title":"Sensitization, glutamate, and the link between migraine and fibromyalgia","volume":"11","author":"Sarchielli","year":"2007","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib158","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ana.10444","article-title":"The neurobiology, diagnosis, and treatment of narcolepsy","volume":"53","author":"Scammell","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib159","first-page":"222","article-title":"The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy","volume":"46","author":"Scharf","year":"1985","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainresbull.2004.01.003","article-title":"GABAC receptor mediated inhibition in acutely isolated neurons of the rat dorsal lateral geniculate nucleus","volume":"63","author":"Schlicker","year":"2004","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib161","first-page":"161","article-title":"Relationship between the discriminative stimulus properties and subjective effects of drugs","volume":"4","author":"Schuster","year":"1988","journal-title":"Psychopharmacol Ser"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib162","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00007611-200006000-00002","article-title":"Drug-facilitated sexual assault (\u2018date rape\u2019)","volume":"93","author":"Schwartz","year":"2000","journal-title":"South Med J"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib163","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/sleep\/13.6.479","article-title":"The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study","volume":"13","author":"Scrima","year":"1990","journal-title":"Sleep"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib164","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/alcalc\/37.2.128","article-title":"Gamma-hydroxybutyric acid versus alcohol preference in Sardinian alcohol-preferring rats","volume":"37","author":"Serra","year":"2002","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02246035","article-title":"Failure of gamma-hydroxybutyrate to alter the function of the GABAA receptor complex in the rat cerebral cortex","volume":"104","author":"Serra","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib166","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejphar.2003.10.045","article-title":"Neuroleptic-like effects of gamma-hydroxybutyrate: interactions with haloperidol and dizocilpine","volume":"483","author":"Sevak","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib167","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2005.05.043","article-title":"Streptozotocin-induced diabetes differentially modulates haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy","volume":"517","author":"Sevak","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib168","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0028-3908(80)90055-6","article-title":"Generalization and antagonism studies with convulsant, GABAergic and anticonvulsant drugs in rats trained to discriminate pentylenetetrazol from saline","volume":"19","author":"Shearman","year":"1980","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib169","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.alcohol.2004.07.014","article-title":"Substitution profiles of N-methyl-d-aspartate antagonists in ethanol-discriminating inbred mice","volume":"34","author":"Shelton","year":"2004","journal-title":"Alcohol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib170","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.pbb.2004.09.022","article-title":"Adolescent gamma-hydroxybutyric acid exposure decreases cortical N-methyl-d-aspartate receptor and impairs spatial learning","volume":"79","author":"Sircar","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib171","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1086-5802(16)30472-7","article-title":"Drugs used in acquaintance rape","volume":"39","author":"Smith","year":"1999","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib172","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2006.08.080","article-title":"The motor-impairing effects of GABAA and GABAB agonists in gamma-hydroxybutyrate (GHB)-treated rats: cross-tolerance to baclofen but not flunitrazepam","volume":"552","author":"Smith","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib173","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1212\/WNL.28.11.1179","article-title":"Gamma hydroxybutyrate in the monkey IV. Dopaminergic mechanisms","volume":"28","author":"Snead","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib174","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(94)90874-5","article-title":"The ontogeny of [3H]\u03b3-hydroxybutyrate and [3H]GABAB binding sites: relation to the development of experimental absence seizures","volume":"659","author":"Snead","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib175","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/0006-2952(96)00477-7","article-title":"Relation of the [3H]\u03b3-hydroxybutyric acid (GHB) binding site to the \u03b3-aminobutyric acidB (GABAB) receptor in rat brain","volume":"52","author":"Snead","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib176","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1212\/WNL.30.8.832","article-title":"Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate","volume":"30","author":"Snead","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib177","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/0006-2952(84)90629-4","article-title":"Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes","volume":"33","author":"Snead","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib178","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0028-3908(93)90163-W","article-title":"GABAA receptor function in the \u03b3-hydroxybutyrate model of generalized absence seizures","volume":"32","author":"Snead","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib179","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0028-3908(87)90173-0","article-title":"\u03b3-Hydroxybutyric acid binding sites: evidence for coupling to a chloride anion channel","volume":"26","author":"Snead","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib180","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/0024-3205(66)90245-1","article-title":"Neuropharmacological effects of 1,4-butanediol and related congeners compared with those of gamma-hydroxybutyrate and gamma-butyrolactone","volume":"5","author":"Sprince","year":"1966","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib181","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1520\/JFS15523J","article-title":"Drug-facilitated sexual assault involving gamma-hydroxybutyric acid","volume":"47","author":"Stillwell","year":"2002","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib182","first-page":"152","article-title":"Effects of gamma-hydroxybutyrate on ventral tegmental unit activity in the rat: considerations on rem sleep control","volume":"1","author":"Tremblay","year":"1998","journal-title":"Sleep Res Online"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib183","first-page":"21645","article-title":"Placement of gamma-butyrolactone in List I of the Controlled Substances Act (21 U.S.C. 802(34))","volume":"65","author":"United States Federal Register","year":"2000"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib184","first-page":"13235","article-title":"Schedules of controlled substances: addition of gamma-hydroxybutyric acid to Schedule I","volume":"65","author":"United States Federal Register","year":"2000"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib185","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1211\/002235703765344513","article-title":"Tolerance to the hypnotic and electroencephalographic effect of gamma-hydroxybutyrate in the rat: pharmacokinetic and pharmacodynamic aspects","volume":"55","author":"Van Sassenbroeck","year":"2003","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib186","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/emj.2002.002402","article-title":"Gamma hydroxybutyrate use for sexual assault","volume":"21","author":"Varela","year":"2004","journal-title":"Emerg Med J"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib187","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/j.1471-4159.1989.tb09183.x","article-title":"Gamma-hydroxybutyrate stimulation of the formation of cyclic GMP and inositol phosphates in rat hippocampal slices","volume":"52","author":"Vayer","year":"1989","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib188","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004311-196900710-00007","article-title":"Gammahydroxybutyric acid","volume":"7","author":"Vickers","year":"1969","journal-title":"Int Anesthesiol Clin"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib189","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00213-004-2079-0","article-title":"Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons","volume":"179","author":"Weerts","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib190","article-title":"Self-administration of the gamma-hydroxybutyrate (GHB) prodrug gamma-butyrolactone (GBL) in baboons","author":"Weerts","year":"2008","journal-title":"Abstract for the CPDD 70th Annual Scientific Meeting"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib191","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.105.090472","article-title":"Novel cyclic gamma-hydroxybutyrate (GHB) analogs with high affinity and stereoselectivity of binding to GHB sites in rat brain","volume":"315","author":"Wellendorph","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib192","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.lfs.2007.01.050","article-title":"Neuropharmacological profile of tetrahydrofuran in mice","volume":"80","author":"Werewattanachai","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib193","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/BF00426468","article-title":"The stimulus properties of \u03b3-hydroxybutyrate","volume":"73","author":"Winter","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib194","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0028-3908(65)90034-1","article-title":"Various seizure activities following gamma-hydroxybutyrate","volume":"4","author":"Winters","year":"1965","journal-title":"Int J Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib195","first-page":"29","article-title":"Transduction of a discriminative stimulus through a diazepam-insensitive gamma-aminobutyric acid A receptor","volume":"178","author":"Wong","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib196","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0376-8716(98)00153-7","article-title":"Evaluation of the reinforcing and discriminative stimulus effects of \u03b3-hydroxybutyrate in rhesus monkeys","volume":"54","author":"Woolverton","year":"1999","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib197","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.neuropharm.2004.08.019","article-title":"\u03b3-Hydroxybutyric acid (GHB) and \u03b3-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence","volume":"47","author":"Wu","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib198","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/jpet.102.046797","article-title":"A tertiary alcohol analog of gamma-hydroxybutyric acid as a specific gamma-hydroxybutyric acid receptor ligand","volume":"305","author":"Wu","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib199","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-8993(87)90547-6","article-title":"Behavioral actions of baclofen in the rat ventromedial thalamic nucleus: antagonism by delta-aminovalerate","volume":"422","author":"W\u00fcllner","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(92)90347-7","article-title":"\u03b3-Hydroxybutyrate hyperpolarizes hippocampal neurons by activating GABAB receptors","volume":"212","author":"Xie","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.10.003_bib201","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1152\/jn.1999.81.6.2875","article-title":"Different subtypes of GABAB receptors are present at pre- and postsynaptic sites within the rat dorsolateral septal nucleus","volume":"81","author":"Yamada","year":"1999","journal-title":"J Neurophysiol"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725808001964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725808001964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T12:25:22Z","timestamp":1738499122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725808001964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":201,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0163725808001964"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2008.10.003","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}